Daniel Jonker

Daniel Jonker is a Director of Clinical Pharmacology at Ferring Pharmaceuticals, where they leverage extensive experience in Phase I, II, and III clinical drug development. A skilled pharmacometrician, they have developed PK/PD models that guide relevant clinical questions and have contributed to treatment algorithms for various clinical trials. Daniel has a strong regulatory background, including modeling for regulatory interactions and participation in meetings. Prior to their current role, they held positions at Grünenthal, Novo Nordisk, and Uppsala University, and earned a Doctor of Pharmacy from Universiteit Utrecht and a PhD in Pharmacology from Universiteit Leiden.